VulnerabilityAnalyzed

CVE-2024-53693

An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions.

HIGH 7.1EPSS 0.48%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.48%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

An improper neutralization of CRLF sequences ('CRLF Injection') vulnerability has been reported to affect several QNAP operating system versions. If exploited, the vulnerability could allow remote attackers who have gained user access to modify application data. We have already fixed the vulnerability in the following versions: QTS 5.2.3.3006 build 20250108 and later QuTS hero h5.2.3.3006 build 20250108 and later

CVSS 4.0: 7.1 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
EPSS: 0.48% probability · 40th percentile
CISA KEV: Not listed
Weakness: CWE-93, CWE-94, CWE-400
Affected: qnap/qts · qnap/quts hero
Source: security@qnapsecurity.com.tw

References

https://www.qnap.com/en/security-advisory/qsa-24-54Vendor Advisory

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.